AIM
PGNX

Assured Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Assured Investment Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-37,961
Closed -$176K – 1059
2019
Q1 		$176K Sell
37,961
-9,962
-21% -$45.1K ﹤0.01% 821
2018
Q4 		$201K Buy
+47,923
New +$244K 0.01% 881

Other funds holding PGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Assured Investment Management's PGNX Position: Q2 2019 in Review

Assured Investment Management sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2019, closing a stake of 37,961 shares — an estimated $176K sold.

Assured Investment Management first reported a position in PGNX in Q4 2018 and held it in 2 quarters. The position peaked at $201K in Q4 2018. 142 funds tracked by Wall St. Rank hold PGNX as of Q2 2019.

  • Assured Investment Management reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 37,961 Progenics Pharmaceuticals Inc shares in Q2 2019, an estimated $176K.
  • Assured Investment Management first reported a position in Progenics Pharmaceuticals Inc in Q4 2018 and held it in 2 quarters.
  • Assured Investment Management's Progenics Pharmaceuticals Inc position peaked at $201K in Q4 2018.
  • 142 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.